Major Study Confirms Racial Disparities Related to Key Diabetes Indicator, Hemoglobin A1c

Standard Test for Determining Blood Sugar Control in People with Diabetes Is Not Always an Accurate Measure of Blood Sugar Control and Interpretation Differs Based on Race. Boston, MA – June 14, 2017 – T1D Exchange, an organization that is accelerating novel treatments and improving care, today published an important research study that confirms [...]

2017-12-13T07:33:32+00:00 June 14th, 2017|Findings|

T1D Exchange’s Biobank Samples Help Researchers Discover Potential Breakthrough in Understanding and Potentially Treating Diabetic Kidney Disease

Findings shed new light on potential prevention of diabetic kidney and heart disease in patients with type 1 diabetes Men with type 1 diabetes and albuminuria have greater copeptin concentrations than men with normoalbuminuria, according to researchers at the University of Colorado. The findings were published today in the Journal of Diabetes and Its [...]

2017-03-31T08:53:23+00:00 March 20th, 2017|Findings|

Clinical Study Confirms Continuous Glucose Monitoring is as Safe and Effective as Blood Glucose Monitoring

Data from T1D Exchange Are Supportive of FDA’s Approval for New Indication for Dexcom G5® Mobile Continuous Glucose Monitoring System  Boston, MA – T1D Exchange, a nonprofit organization accelerating research to improve outcomes in type 1 diabetes, today published a major research study in Diabetes Care that confirms the use of Continuous Glucose Monitoring (CGM) [...]

2017-02-17T13:01:24+00:00 February 16th, 2017|Findings|

Beyond Type 1 Diabetes: When T1D Isn’t the Only Uninvited House Guest

A T1D Exchange study analyzes the frequency of autoimmune disorders and T1D Are you living with type 1 diabetes and another autoimmune condition? You are not alone. A recent T1D Exchange study reveals that people with type 1 diabetes (T1D) often have other autoimmune disorders, such as thyroid and gastrointestinal diseases. In fact, one of [...]

2017-02-17T13:01:24+00:00 November 7th, 2016|Findings|

Why Do Some People with T1D Stop Using a Pump and CGM?

T1D Exchange researched factors associated with discontinuation of pump and CGM Data show that the use of an insulin pump and/or continuous glucose monitors (CGM) improve glycemic control. Yet, only a small percentage of people with type 1 diabetes (T1D) are using—and benefitting from—these technologies. T1D Exchange researchers analyzed factors associated with device discontinuation from [...]

2017-02-17T13:01:26+00:00 April 20th, 2016|Findings|

Six-Month Clinical Trial Reveals Addition of Metformin Fails to Improve Glycemic Control in Adolescents Living with Type 1 Diabetes

Showed improvements to cardiovascular risks—reduced weight, BMI, total daily insulin usage BOSTON, December 1, 2015––Six months of adjunctive metformin therapy does not improve glycemic outcomes in obese adolescents with type 1 diabetes, according to new research from T1D Exchange and funded by the JDRF. However, it may have a beneficial effect on measures of obesity, [...]

2017-02-17T13:01:26+00:00 December 1st, 2015|Findings|

Insulin Pump Use Varies Across Globe Despite Benefits in Diabetes Control

Age, gender, ethnicity, and geography shown to impact access in largest international study of pediatric insulin pump therapy BOSTON, November 9, 2015 – In one of the largest studies of its kind, T1D Exchange researchers found that although insulin pumps improve blood sugar management, the use of this technology varies significantly—a factor that may play [...]

2017-02-17T13:01:26+00:00 November 9th, 2015|Findings|

T1D Exchange to Present Several Abstracts at the 51st European Association for the Study of Diabetes (EASD) Annual Meeting

Research sheds light on treatment/management issues and common disease comorbidities BOSTON, September 15, 2015 – Investigators from T1D Exchange, a nonprofit dedicated to accelerating discoveries and delivery of new treatments, will present several abstracts on pressing type 1 diabetes issues during the 51st European Association for the Study of Diabetes (EASD) Annual Meeting, held in [...]

2017-02-17T13:01:26+00:00 September 15th, 2015|Findings|

Multinational analysis shows diabetic ketoacidosis (DKA) rates still high among pediatric patients

The largely preventable complication is associated with high treatment costs, contributing to financial burden of healthcare systems, families; better prevention/education programs needed  BOSTON, August 17, 2015 – In the largest multinational analysis of diabetic ketoacidosis (DKA) in pediatric type 1 diabetes patients, T1D Exchange researchers found consistently high rates and common risk factors for DKA [...]

2017-02-17T13:01:26+00:00 August 17th, 2015|Findings|

U.S. Youth with Type 1 Diabetes Overweight, but Obesity Epidemic Also Affecting European Youth

U.S., Germany, and Austria pediatric type 1 diabetes population at increased risk for insulin resistance, cardiovascular disease; the downside of intensive insulin therapy BOSTON, July 8, 2015 – Adolescents with type 1 diabetes have not escaped the global obesity epidemic and those in the U.S. are significantly more overweight than their German and Austrian counterparts, [...]

2017-02-17T13:01:27+00:00 July 8th, 2015|Findings|